ESPB for Kidney Stone Pain
Trial Summary
What is the purpose of this trial?
This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking strong CYP1A2 inhibitors like fluvoxamine, amiodarone, or fluoroquinolones.
What data supports the idea that ESPB for Kidney Stone Pain is an effective treatment?
The available research shows that ESPB is effective in managing pain after surgeries, including those related to the kidneys. For example, one study found that ESPB helped control pain after kidney surgery, specifically in patients who had a nephrectomy, which is the removal of a kidney. Another study compared ESPB to patient-controlled pain relief methods and found that ESPB was effective in reducing pain after kidney surgery. These studies suggest that ESPB can be a good option for managing pain after kidney-related procedures.12345
What safety data exists for ESPB in treating kidney stone pain?
The safety of the erector spinae plane block (ESPB) has been evaluated in various studies, primarily focusing on its efficacy and safety for postoperative analgesia in surgeries like percutaneous nephrolithotomy (PCNL) and open nephrectomy. These studies suggest that ESPB is a simple and safe interfascial plane block that provides effective postoperative pain relief. However, specific safety data for ESPB in the context of kidney stone pain is limited, and more evidence is needed to fully establish its safety profile in this specific application.12367
Is the treatment Erector Spinae Plane Block (ESPB) promising for kidney stone pain?
Research Team
Chris Fung
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for adults with confirmed kidney stones who've had pain medication in the ER. It's not for pregnant or breastfeeding individuals, prisoners, those on blood thinners or with clotting issues, local anesthetic allergies, active COVID-19 infection, UTI treatments, prior thoracic spine surgery, skin infections at the injection site, strong CYP1A2 inhibitor users or G6PD deficiency.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Erector Spinae Plane Block (ESPB) for kidney stone pain
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Erector Spinae Plane Block (ESPB) (Procedure)
- Ropivacaine (Local Anesthetic)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Marschall S. Runge
University of Michigan
Chief Executive Officer since 2015
MD, PhD
Karen McConnell
University of Michigan
Chief Medical Officer since 2020
MD